Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Drugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

A little less than a year after cutting the ribbon at a new glass syringe factory in Hungary, Schott Pharma is making good on ...

Amneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...

Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

With those findings in mind, the ABPI recommended in the report that pharmas “explore the appropriate use of social media ...